Abstract
Alexander disease, a rare fatal disorder of the central nervous system, causes progressive loss of motor and mental function. Until recently it was of unknown etiology, almost all cases were sporadic, and there was no effective treatment. It was most common in an infantile form, somewhat less so in a juvenile form, and was rarely seen in an adult-onset form. A number of investigators have now shown that almost all cases of Alexander disease have a dominant mutation in one allele of the gene for glial fibrillary acidic protein (GFAP) that causes replacement of one amino acid for another. Only in very rare cases of the adult-onset form is the mutation present in either parent. Thus, in almost all cases, the mutation arises as a spontaneous event, possibly in the germ cell of one parent.
Similar content being viewed by others
references
Russo, L. S., Jr., Aron, A., and Anderson, P. J. 1976. Alexander's disease: a report and reappraisal. Neurology 26:607–614.
Escourolle, R., de Baecque, C., Gray, F., Baumann, N., and Hauw, J. J. 1979. Etude en microscopie electronique et neurochimique d'un cas de maladie d'Alexander. Acta Neuropathol. (Berl) 45:133–140.
Borrett, D. and Becker, L. E. 1985. Alexander's disease. A disease of astrocytes. Brain 108(part 2):367–385.
Pridmore, C. L., Baraitser, M., Harding, B., Boyd, S. G., Kendall, B., and Brett, E. M. 1993 Alexander's disease: clues to diagnosis. J. Child Neurol. 8:134–144.
Johnson, A. B. 1996. Alexander disease. Pages 701–710, in Moser, H. W. (ed), Neurodystrophies and neurolipidoses, handbook of clinical neurology, vol 66 (revised series vol 22). Elsevier Science, Amsterdam.
Johnson, A. B. 2002. Alexander disease: a review and the gene. Int. J. Dev. Neurosci. 20:391–394.
Johnson, A. B. 2002. Alexander disease. In Gilman S. (ed.), Medlink neurology. Medlink Corporation, San Diego (Published electronically, at www.medlink.com, updated annually).
Johnson, A. B. and Brenner, M. 2003. Alexander disease: clinical, pathologic, and genetic features. J. Child Neurol. 2003: 18:625–632.
Alexander, W. S. 1949. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 72:373–381.
van der Knaap, M. S., Naidu, S., Breiter, S. N., Blaser, S., Stroink, H., Springer, S., Begeer, J. C., van Coster, R., Barth, P. G., Thomas, N. H., Valk, J., and Powers, J. M. 2001 Alexander disease: diagnosis with MR imaging. AJNR Am. J. Neuroradiol. 22:541–552.
Mastri, A. R. and Sung, J. H. 1973. Diffuse Rosenthal fiber formation in the adult: a report of four cases. J. Neuropathol. Exp. Neurol. 32:424–436.
Howard, R. S., Greenwood, R., Gawler, J., Scaravalli, F., Marsden, C. D., and Harding, A. E. 1993. A familial disorder associated with palatal myoclonus, other brainstem signs, tetraparesis, ataxia and Rosenthal fiber formation. J. Neurol. Neurosurg. Psychiatry 56:977–981.
Honnorat, J., Flocard, F., Ribot, C., Saint-Pierre, G., Pineau, D., and Peysson, P. 1993. Alexander's disease in adults and diffuse cerebral gliomatosis in 2 members of the same family [in French]. Rev. Neurol. (Paris) 149:781–787.
Schwankhaus, J. D., Parisi, J. E., Gulledge, W. R., Chin, L., and Currier, R. D. 1995. Hereditary adult-onset Alexander's disease with palatal myoclonus, spastic paraparesis, and cerebellar ataxia. Neurology 45:2216–2271.
Okamoto, Y., Mitsuyama, H., Jonosono, M., Hirata, K., Arimura, K., Osame, M., and Nakagawa, M. 2002. Autosomal dominant palatal myoclonus and spinal cord atrophy. J. Neurol. Sci. 195:71–76.
Johnson, A. B. and Bettica, A. 1989. On-grid immunogold labeling of glial intermediate filaments in epoxy-embedded tissue. Am. J. Anat. 185:335–341.
Iwaki, T., Kume-Iwaki, A., Liem, R. K. H., and Goldman, J. E. 1989. αB-Crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 57:71–78.
Tomokane, N., Iwaki, T., Tateishi, J., Iwaki, A., and Goldman, J. E. 1991. Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. Am. J. Pathol. 138:875–885.
Iwaki, A., Iwaki, T., Goldman, J. E., Ogomori, K., Tateishi, J., and Sakaki, Y. 1992. Accumulation of αB-crystallin in brains of patients with Alexander's disease is not due to an abnormality of the 5′-flanking and coding sequence of the genomic DNA. Neurosci. Lett. 140:89–92.
Head, M. W., Corbin, E., and Goldman, J. E. 1993. Overexpression and abnormal modification of the stress proteins αB-crystallin and HSP27 in Alexander disease. Am. J. Pathol. 143:1743–1753.
Messing, A., Head, M. W., Galles, K., Galbreath, E. J., Goldman, J. E., and Brenner, M. 1998. Fatal encephalopathy with astro-cyte inclusions in GFAP transgenic mice. Am. J. Pathol. 152:391–398.
Brenner, M., Johnson, A. B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. E., and Messing, A. 2001. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27:117–120.
Messing, A., Goldman, J. E., Johnson, A. B., and Brenner, M. 2001. Alexander disease: new insights from genetics. J. Neuropathol. Exp. Neurol. 60:563–573.
Rodriguez, D., Gautier, F., Bertini, E., Bugiani, M., Brenner, M., N'guyen, S., Goizet, C., Gelot, A., Surtees, R., Pedespan, J. M., Hernandorena, X., Troncoso, M., Uziel, G., Messing, A., Ponsot, G., Pham-Dinh, D., Dautigny, A., and Boespflug-Tanguy, O. 2001. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am. J. Hum. Genet. 69:1134–1140.
Aoki, Y., Haginoya, K., Munakata, M., Yokoyama, H., Nishio, T., Togashi, N., Ito, T., Suzuki, Y., Kure, S., Iinuma, K., Brenner, M., and Matsubara, Y. 2001. A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease. Neurosci. Lett. 312:71–74.
Shiroma, N., Kanazawa, N., Izumi, M., Sugal, K., Sasaki, M., Hanaoka, S., Kaga, M., and Tsujino, S. 2001. Diagnosis of Alexander disease in a Japanese patient by molecular genetic analysis. J. Hum. Genet. 46:579–582.
Gorospe, J. R., Naidu, S., Johnson, A. B., Puri, V., Raymond, G. V., Jenkins, S. D., Pedersen, R. C., Lewis, D., Knowles, P., Fernandez, R., De Vivo, D., van der Knaap, M. S., Messing, A., Brenner, M., and Hoffman, E. P. 2002. Molecular findings in symptomatic and presymptomatic Alexander disease patients. Neurology 58:1494–1500.
Meins, M., Brockmann, K., Yadav, S., Haupt, M., Sperner, J., Stephani, U., and Hanefeld, F. 2002. Infantile Alexander disease: A GFAP mutation in monozygotic twins and novel mutations in two other patients. Neuropediatrics 33:194–198.
Namekawa, M., Takiyama, Y., Aoki, Y., Takayashiki, N., Sakoe, K., Shimazaki, H., Taguchi, T., Tanaka, Y., Nishizawa, M., Saito, K., Matsubara, Y., and Nakano, I. 2002. Identification of GFAP gene mutation in hereditary adult-onset Alexander's disease. Ann. Neurol. 52:779–785.
Sawaishi, Y., Yano, T., Takaku, I., and Takada, G. 2002. Juvenile Alexander disease with a novel mutation in glial fibrillary acidic protein gene. Neurology 58:1541–1543.
Shiihara, T., Kato, M., Honma, T., Ohtaki, S., Sawaishi, Y., and Hayasaka, K. 2002. Fluctuation of computed tomographic findings in white matter in Alexander's disease. J. Child. Neurol. 17:227–230.
Probst, E. N., Hagel, C., Weisz, V., Nagel, S., Wittkugel, O., Zeumer, H., and Kohlschutter, A. 2003. Atypical focal MRI lesions in a case of juvenile Alexander's disease. Ann. Neurol. 53:118–120.
Shiroma, N., Kanazawa, N., Kato, Z., Shimozawa, N., Imamura, A., Ito, M., Ohtani, K., Oka, A., Wakabayashi, K., Iai, M., Sugai, K., Sasaki, M., Kaga, M., Ohta, T., and Tsujino, S. 2003. Molecular genetic study in Japanese patients with Alexander disease: a novel mutation, R79L. Brain Dev. 25:116–121.
Li, R., Messing, A., Goldman, J. E., and Brenner, M. 2002. GFAP mutations in Alexander disease. Int. J. Dev. Neurosci. 20:259–268.
Nielsen, A. L., Jorgensen, P., and Jorgensen, A. L. 2002. Mutations associated with a childhood leukodystrophy, Alexander disease, cause deficiency in dimerization of the cytoskeleton protein GFAP. J. Neurogenet. 16:175–179.
Castellani, R. J., Perry, G., Harris, P. L. R., Monnier, V. M., Cohen, M. L., and Smith, M. A. 1997. Advanced glycation modification of Rosenthal fibers in patients with Alexander disease. Neurosci. Lett. 231:79–82.
Castellani, R. J., Perry, G., Harris, P. L. R., Cohen, M. L., Sayre, L. M., Salomon, R. G., and Smith, M. A. 1998. Advanced lipid peroxidation end-products in Alexander's disease. Brain Res. 787:15–18.
Gingold, M. K., Bodensteiner, J. B., Schochet, S. S., and Jaynes, M. 1999. Alexander's disease: unique presentation. J. Child. Neurol. 14:325–329.
Liedtke, W., Edelmann, W., Bieri, P. L., Chiu, F. C., Cowan, N. J., Kucherlapati, R., and Raine, C. S. 1996. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17:607–615.
McCall, M. A., Gregg, R. G., Behringer, R. R., Brenner, M., Delaney, C. L., Galbreath, E. J., Zhang, C. L., Pearce, R. A., Chiu, S. Y., and Messing, A. 1996. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc. Natl. Acad. Sci. USA 93:6361–6366.
Messing, A. and Brenner, M. 2003. GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 43:87–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnson, A.B. Alexander Disease: A Leukodystrophy Caused by a Mutation in GFAP . Neurochem Res 29, 961–964 (2004). https://doi.org/10.1023/B:NERE.0000021240.30518.2c
Issue Date:
DOI: https://doi.org/10.1023/B:NERE.0000021240.30518.2c